QUILLIVANTXR

NextWave Pharmaceuticals, Inc.

Application Filed: 2012-08-15
Trademark Application Details
Trademark Logo QUILLIVANTXR
602
Dead/Abandoned
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Research OneLook Acronym Finder
Serial Number85704153
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameRichard A. Friedman
Attorney Docket NumberT401637
Law Office AssignedM80
Employee NameARANT, LUCY B

Timeline

2012-08-15Application Filed
2013-01-14Date of First Use
2013-01-22Published for Opposition
2014-04-11Abandon
2014-05-11Location: LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
2014-05-11Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: NextWave Pharmaceuticals, Inc.
AddressSuite 150 20450 Stevens Creek Boulevard Cupertino DE 95014
Legal Entity TypeCorporation
Legal Entity StateDE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Richard A. Friedman
Pfizer Inc.
235 East 42nd Street
New York NY 10017

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2012-08-181 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2012-08-222 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2012-12-113 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER2012-12-114 CNSA P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2012-12-135 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2012-12-136 ARAA I:Incoming Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2013-01-027 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2013-01-228 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2013-01-229 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2013-03-1910 NOAM E:E-Mail
TEAS STATEMENT OF USE RECEIVED2013-08-2911 EISU I:Incoming Correspondence
TEAS EXTENSION RECEIVED2013-08-2912 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL2013-10-0313 AITU A:Allowance for Publication
EXTENSION 1 FILED2013-08-2914 EXT1 S:
EXTENSION 1 GRANTED2013-10-1015 EX1G S:
USE AMENDMENT FILED2013-08-2916 IUAF S:
STATEMENT OF USE PROCESSING COMPLETE2013-10-1017 SUPC I:Incoming Correspondence
SU - NON-FINAL ACTION - WRITTEN2013-10-1018 CNRT W:
NON-FINAL ACTION E-MAILED2013-10-1019 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2013-10-1020 GNRN O:Outgoing Correspondence
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2013-10-1121 EXRA E:E-Mail
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2014-05-1122 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND2014-05-1223 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed